| Literature DB >> 29065512 |
Kuei-Hung Lai1, Wan-Jing You2,3, Chi-Chen Lin4, Mohamed El-Shazly5,6, Zuo-Jian Liao7,8,9, Jui-Hsin Su10,11.
Abstract
Abstract: Cembrane-type diterpenoids are among the most frequently encountered natural products from the soft corals of the genus Lobophytum. In the course of our investigation to identify anti-inflammatory constituents from a wild-type soft coral Lobophytumcrassum, two new cembranoids, lobophyolide A (1) and B (2), along with five known compounds (3-7), were isolated. The structures of these natural products were identified using NMR and MS spectroscopic analyses. Compound 1 was found to possess the first identified α-epoxylactone group among all cembrane-type diterpenoids. The in vitro anti-inflammatory effect of compounds 1-5 was evaluated. The results showed that compounds 1-5 not only reduced IL-12 release, but also attenuated NO production in LPS-activated dendritic cells. Our data indicated that the isolated series of cembrane-type diterpenoids demonstrated interesting structural features and anti-inflammatory activity which could be further developed into therapeutic entities.Entities:
Keywords: IL-12 production; NO release; cembranoids; lobophyolides; α-epoxylactone group
Mesh:
Substances:
Year: 2017 PMID: 29065512 PMCID: PMC5666433 DOI: 10.3390/md15100327
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structural characteristics of cembrane-type diterpenoids.
Figure 2Cembranoids isolated from the soft coral Lobophytum crassum.
1H, 13C, 1H–1H COSY, and HMBC NMR data of 1.
| Position | 1H–1H COSY | HMBC | ||
|---|---|---|---|---|
| 1 | 2.26 m | 39.0 (CH) | H-2, H-14 | |
| 2 | 5.06 dd (10.0, 4.5) | 79.4 (CH) | H-1, H-3 | C-16 |
| 3 | 5.17 d (10.0) | 122.7 (CH) | C-5 | |
| 4 | 142.5 (C) | |||
| 5 | 2.22 m | 38.4 (CH2) | ||
| 6 | 2.21 m; 2.30 m | 24.1 (CH2) | H-7 | |
| 7 | 4.89 t (5.0) | 125.1 (CH) | H-6 | C-5, C-9 |
| 8 | 133.8 (C) | |||
| 9 | 1.99 m; 2.12 m | 39.0 (CH2) | ||
| 10 | 2.07 m; 2.20 m | 23.9 (CH2) | H-11 | |
| 11 | 4.93 t (5.0) | 125.2 (CH) | H-10 | C-9, C-13 |
| 12 | 131.4 (C) | |||
| 13 | 2.03 m | 35.1 (CH2) | H-14 | |
| 14 | 1.55 m; 1.77 m | 24.2 (CH2) | H-13, H-1 | C-2, C-15 |
| 15 | 57.9 (C) | |||
| 16 | 173.8 (C) | |||
| 17 | 2.96 d (6.0); 3.30 d (6.0) | 52.2 (CH2) | C-1, C-15, C-16 | |
| 18 | 1.74 s | 16.4 (CH3) | C-3, C-4, C-5 | |
| 19 | 1.59 s | 15.2 (CH3) | C-7, C-8, C-9 | |
| 20 | 1.52 s | 15.9 (CH3) | C-11, C-12, C-13 |
Spectra recorded at 500 and 125 MHz in CDCl3.
Figure 3Selective 1H–1H COSY, HMBC, and NOESY correlations of 1.
1H, 13C, 1H–1H COSY, and HMBC NMR data of 2.
| Position | 1H–1H COSY | HMBC | ||
|---|---|---|---|---|
| 1 | 3.26 dd (3.0, 2.0) | 41.9 (CH) | H-2 | |
| 2 | 4.97 d (3.5) | 80.2 (CH) | H-1 | C-3, C-14 |
| 3 | 209.9 (C) | |||
| 4 | 2.66 m | 41.8 (CH) | H-5, H-18 | |
| 5 | 1.46 m; 1.95 m | 31.3 (CH2) | H-4, H-6 | |
| 6 | 1.83 m; 2.20 m | 26.0 (CH2) | H-5, H-7 | |
| 7 | 4.98 m | 125.7 (CH) | H-6 | C-9 |
| 8 | 135.2 (C) | |||
| 9 | 2.04 m; 2.18 m | 39.3 (CH2) | H-9, H-11 | |
| 10 | 2.13 m; 2.24 m | 24.4 (CH2) | H-11 | |
| 11 | 5.20 t (6.3) | 130.3 (CH) | H-10 | C-13 |
| 12 | 129.3 (C) | |||
| 13 | 2.31 d (13.0); 2.45 dd (15.0, 11.0) | 41.1 (CH2) | H-14 | C-1 |
| 14 | 5.09 dt (11.0, 2.5) | 75.6 (CH) | H-13 | |
| 15 | 135.1 (C) | |||
| 16 | 169.5 (C) | |||
| 17 | 5.73 d (2.5); 6.42 d (2.5) | 124.8 (CH2) | C-1, C-15, C-16 | |
| 18 | 1.14 d (7.0) | 17.7 (CH3) | C-3, C-4, C-5 | |
| 19 | 1.49 s | 15.0 (CH3) | C-7, C-8, C-9 | |
| 20 | 1.72 s | 16.1 (CH3) | C-11, C-12, C-13 | |
| 14-OAC | 2.02 s | 21.0 (CH3) | C-14-OAc | |
| 170.0 (C) |
Spectra recorded at 500 and 125 MHz in CDCl3.
Figure 4Selective 1H–1H COSY, HMBC, and NOESY correlations of 2.
Inhibition of LPS-induced IL-12 release and NO production in dendritic cells.
| Compounds | LPS-Induced IL-12 Release | LPS-Induced NO Production | Survivals of DCs |
|---|---|---|---|
| (Inh%) | (Inh%) | (Survival%) | |
| 1 | 93.4 ± 0.5 | 93.5 ± 6.5 | 76.0 ± 0.01 |
| 2 | 93.6 ± 0.0 | 95.9 ± 3.2 | 52.0 ± 0.04 |
| 3 | 86.3 ± 1.1 | 86.1 ± 2.2 | 75.0 ± 0.01 |
| 4 | 77.0 ± 1.5 | 54.9 ± 0.0 | 85.0 ± 0.08 |
| 5 | 92.6 ± 0.6 | 96.2 ± 2.2 | 51.0 ± 0.01 |
| Quercetin | 86.4 ± 0.0 | 86.1 ± 3.0 | 85.0 ± 5.00 |
Percentage of inhibition (Inh%) under the concentration of 50 μg/mL; Survival percentage (Survival%) of DCs under the concentration of 50 μg/mL; Positive control under the concentration of 50 μM.